Drug interactions
Ketorolac intranasal + Valganciclovir
Severity: Minor
Ketorolac intranasal and Valganciclovir: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Ketorolac is an organic anion that may compete with ganciclovir for tubular secretion, and NSAIDs can reduce renal function. Intranasal dosing gives systemic exposure, but the effect is likely small with short-term use.
What this interaction means in plain words
Ketorolac intranasal and Valganciclovir have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Why it happens
Possible competition for renal tubular anion secretion; NSAID effect on renal perfusion may reduce clearance.
What to do
Limit ketorolac to short courses and monitor renal function. Adjust valganciclovir dose to creatinine clearance if renal function declines.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Ketorolac intranasal and Valganciclovir, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Valganciclovir
Frequently asked questions
Can I take Ketorolac intranasal with Valganciclovir?
MediHelp rates the interaction as minor. Ketorolac intranasal and Valganciclovir have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Ketorolac is an organic anion that may compete with ganciclovir for tubular secretion, and NSAIDs can reduce renal function. Intranasal dosing gives systemic exposure, but the effect is likely small with short-term use.
How serious is the interaction between Ketorolac intranasal and Valganciclovir?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Limit ketorolac to short courses and monitor renal function. Adjust valganciclovir dose to creatinine clearance if renal function declines.
What other medicines interact with Valganciclovir?
MediHelp also lists interactions of Valganciclovir with, for example, Didanosine, Ganciclovir, Liposomal doxorubicin. The full list is on the Valganciclovir page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
